徐国辰，男，博士，心血管专业，副主任医师。1983~1989第四军医大学医疗系本科，获学士学位；1991~1994第四军医大学研究生院心血管病学专业，获硕士学位；2003~2005第四军医大学药学系....

徐国辰，男，博士，心血管专业，副主任医师。1983~1989第四军医大学医疗系本科，获学士学位；1991~1994第四军医大学研究生院心血管病学专业，获硕士学位；2003~2005第四军医大学药学系药理学专业/北京大学人民医院心血管病研究所，获博士学位。师从张宁仔、杜日映教授攻读硕士学位期间，从事全军“八五”攻关课题“血管支架预防/治疗PTA/PTCA术后急性闭塞与慢性再狭窄”研究，研制成功首例国产不锈钢动脉血管支架。师从梅其柄、胡大一教授攻读博士学位期间，从事“药物基因组学与脂代谢紊乱患者的个体化治疗”研究，开始涉足药物相互作用和药物个体化治疗与遗传基因多态性的相关研究领域。自2000年从事心血管专科门诊工作以来，开展心血管疾病的循证医学研究，发表相关研究论文20余篇，参编心血管病学专著2部。2000年获国家卫生部、中国中医药管理局、解放军总后勤部联合举办的“中国中医药科技大会”优秀论文奖；2004年赴新加坡参加“亚洲青年心血管病专家论坛”国际会议，就在中国本土开展的“药物基因组学与脂代谢紊乱患者的个体化治疗研究”发表演讲。Dr.XuGuochen,associatechiefphysician,specializesincardiovasculardiseases.Dr.Xugraduatedfromthedepartmentofmedicine(six-yearcourse)oftheFourthMilitaryMedicalUniversityin1989,andwasawardedMedicalBachelorDegree.HemajoredcardiovasculardiseasesatgraduateschooloftheFourthMilitaryMedicalUniversityfrom1991to1994,andwasawardedMasterDegreeofMedicalScience.HemajoredincardiovascularpharmacologyatthedepartmentofpharmacologyoftheFourthMilitaryMedicalUniversityandAngiocardiopathyInstituteofPekingUniversityPeople'sHospitalfrom2002to2005,andwasawardedDoctoralDegreeofMedicalScience.Dr.XustudiedformasterdegreeundersupervisionofprofessorsZhangNingziandDuRiying,andhisresearchwasfocusedonPreventing/CuringPTA/PTCAPostoperativeAcuteClosureandChronicRestenosisbyusingStentforKeyTechnologiesResearchandDevelopmentProgramofthearmyduringthe8thFive-YearPlanPeriod.HesuccessfullydevelopedthefirstdomesticstainlesssteelcoronarystentinChina.Dr.Xu’sdoctoralstudyonpharmacogenomicsofindividualizedtreatmentoflipidmetabolismdisorderwasconductedundersupervisionofprofessorsMeiQibingandHuDayi.MeanwhileDr.Xuinitiatedtheinvestigationondruginteractions,clinicalindividualizedtreatmentgeneticpolymorphism.Dr.Xuhasbeenworkingonevidence-basedcardiovascularmedicinesince2000.Hehaspublishedmorethan20researcharticles,andparticipatedincompilingoftwocardiovasculogicalmonographs,andwonthePrizefortheExcellentPapersinChinaTechnologyConferenceonTCMco-sponsoredbyMinistryofPublicHealth,StateAdministrationofTraditionalChineseMedicineandTheGeneralLogisticsDepartmentofPLAin2000.HepresentedorallyhisstudyonpharmacogenomicsofindividualizedtreatmentoflipidmetabolismdisorderattheInternationalConferenceofAsianYouthSpecialistForumonAngiocardiopathyinSingaporein2004.